AMEX · LSF

Laird Superfood, Inc.

$4.20 +$0.44 (+11.70%) 1D Market open

Key Metrics

$41.38M
Market cap
P/E · TTM
$52.18M
Revenue · TTM
−$1.35M
Net income
EPS · TTM $-0.13
Dividend yield
Free cash flow
Beta · 1Y 1.53
EBITDA · TTM −$5.86M
Gross margin 35.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 21
    2 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 2, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 16
    The stock moved +14.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 16
  • Apr 15
    The stock moved +13.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 15
  • Mar 27
    From its Jan 29 high, the share price fell 34%.

    Peak close $3.11 on Jan 29; trough close $2.05 on Mar 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$41.38M
Enterprise value
Shares outstanding11.0M
52-wk range$1.96 – $7.21
Avg volume · 20D99.4K
Net cash
Book value / share$1.31
IndustryFood And Kindred Products
ExchangeAMEX
About Laird Superfood, Inc.
IPO dateSep 23, 2020
Employees28

Laird Superfood Inc is engaged in the development and marketing of food and beverage products focused on health and wellness.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.79
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 35.8%
Operating -11.9%
Net -2.6%
FCF
ROE / ROIC -10.1% · -42.1%

Financial Health

Current ratio3.19
Quick ratio1.72
Debt / equity
Debt / EBITDA
Net cash
Working capital$25.75M

Cash Flow · TTM

Operating CF −$5.34M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.9
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings